Task Five: Conversion of Legacy Clinical Trials Data to SDTM for Analysis by Sex in the OWH.Task Five: Conversion of Legacy Clinical Trials Data to SDTM for Analysis by Sex in the OWH.

Support to convert legacy clinical trials data on angiotensin receptor blockers approved by FDA/CDER to CDISC-compliant SDTM standard format (v3.1.2) to enable sex analysis of the data. Data Management and Programming Support: Indefinite Delivery Indefinite Quantity (IDIQ) contract award from the US Food and Drug Administration (FDA).

Principal Investigators:

  • Bruce W. Thompson, Ph.D.